These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10332570)

  • 21. [Replacement and supplementation of DHEA--is it a wellness hormone?].
    Brückel J
    MMW Fortschr Med; 2005 Feb; 147(7):30-2. PubMed ID: 18441581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DHEA replacement for postmenopausal women: placebo or panacea?
    Eden JA
    Climacteric; 2015; 18(4):439-40. PubMed ID: 25731680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dehydroepiandrosterone: is there a role for replacement?
    Dhatariya KK; Nair KS
    Mayo Clin Proc; 2003 Oct; 78(10):1257-73. PubMed ID: 14531485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydroepiandrosterone Research: Past, Current, and Future.
    Klinge CM; Clark BJ; Prough RA
    Vitam Horm; 2018; 108():1-28. PubMed ID: 30029723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R; Barbetta L; Dall'Asta C; Salvaggio F; Gala C; Beck-Peccoz P; Ambrosi B
    J Endocrinol Invest; 2004 Sep; 27(8):736-41. PubMed ID: 15636426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dehydroepiandrosterone and ageing.
    Arlt W
    Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):363-80. PubMed ID: 15261843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dehydroepiandrosterone replacement in elderly men on event-related potentials, memory, and well-being.
    Wolf OT; Naumann E; Hellhammer DH; Kirschbaum C
    J Gerontol A Biol Sci Med Sci; 1998 Sep; 53(5):M385-90. PubMed ID: 9754145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD; Stomati M; Bernardi F; Pieri M; Rovati L; Genazzani AR
    Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity.
    Callies F; Fassnacht M; van Vlijmen JC; Koehler I; Huebler D; Seibel MJ; Arlt W; Allolio B
    J Clin Endocrinol Metab; 2001 May; 86(5):1968-72. PubMed ID: 11344193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DS) as therapeutic options in menopause.
    Katz S; Morales AJ
    Semin Reprod Endocrinol; 1998; 16(2):161-70. PubMed ID: 9711682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dehydroepiandrosterone and body fat.
    Clore JN
    Obes Res; 1995 Nov; 3 Suppl 4():613S-616S. PubMed ID: 8697065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial.
    Villareal DT; Holloszy JO
    JAMA; 2004 Nov; 292(18):2243-8. PubMed ID: 15536111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dehydroepiandrosterone therapy as female androgen replacement.
    Saltzman E; Guay A
    Semin Reprod Med; 2006 Apr; 24(2):97-105. PubMed ID: 16633983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Nordmark G; Bengtsson C; Larsson A; Karlsson FA; Sturfelt G; Rönnblom L
    Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DHEA: why, when, and how much--DHEA replacement in adrenal insufficiency.
    Allolio B; Arlt W; Hahner S
    Ann Endocrinol (Paris); 2007 Sep; 68(4):268-73. PubMed ID: 17689478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence.
    Genazzani AR; Pluchino N
    Climacteric; 2010 Aug; 13(4):314-6. PubMed ID: 20540592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
    Poretsky L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison MC; Haller I; Rabkin J
    Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DHEA in elderly women and DHEA or testosterone in elderly men.
    Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
    N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy].
    Krysiak R; Frysz-Naglak D; Okopień B
    Pol Merkur Lekarski; 2008 Jan; 24(139):66-71. PubMed ID: 18634257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.